Back to Search Start Over

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Authors :
Wei Xu
Jin-Hua Liang
Li Wang
Xiao-Dong Wang
Guohui Cui
Jianfeng Zhou
Jingyan Xu
Luqun Wang
Rong Liang
Bi-yun Chen
Jian Cheng
Jian-Yong Li
Source :
Blood. 140:9484-9486
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Subjects

Subjects :
Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........ac7a77477774ba3d0dd49a0dd1e2bdb0
Full Text :
https://doi.org/10.1182/blood-2022-157014
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details